Fjarde Ap-fonden’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,680
| Closed | -$896K | – | 498 |
|
|
2025
Q1 | $896K | Buy |
3,680
+200
| +6% | +$48.7K | 0.01% | 502 |
|
|
2024
Q4 | $1.14M | Buy |
3,480
+1,200
| +53% | +$394K | 0.01% | 507 |
|
|
2024
Q3 | $763K | Buy |
+2,280
| New | +$763K | 0.01% | 507 |
|
|
2024
Q1 | $1.35M | Sell |
3,900
-300
| -7% | -$104K | 0.01% | 513 |
|
|
2023
Q4 | $1.36M | Buy |
4,200
+100
| +2% | +$32.3K | 0.02% | 508 |
|
|
2023
Q3 | $1.47M | Buy |
4,100
+3,300
| +413% | +$1.18M | 0.02% | 509 |
|
|
2023
Q2 | $303K | Hold |
800
| – | – | ﹤0.01% | 527 |
|
|
2023
Q1 | $383K | Buy |
+800
| New | +$383K | 0.01% | 523 |
|
|
2022
Q4 | – | Sell |
-3,147
| Closed | -$1.56M | – | 520 |
|
|
2022
Q3 | $1.56M | Hold |
3,147
| – | – | 0.02% | 519 |
|
|
2022
Q2 | $1.56M | Sell |
3,147
-2,200
| -41% | -$1.09M | 0.02% | 519 |
|
|
2022
Q1 | $3.01M | Sell |
5,347
-1,003
| -16% | -$565K | 0.03% | 487 |
|
|
2021
Q4 | $4.8M | Sell |
6,350
-250
| -4% | -$189K | 0.04% | 409 |
|
|
2021
Q3 | $4.92M | Sell |
6,600
-300
| -4% | -$224K | 0.05% | 403 |
|
|
2021
Q2 | $4.45M | Sell |
6,900
-200
| -3% | -$129K | 0.04% | 445 |
|
|
2021
Q1 | $4.06M | Buy |
7,100
+600
| +9% | +$343K | 0.04% | 451 |
|
|
2020
Q4 | $3.79M | Sell |
6,500
-1,500
| -19% | -$874K | 0.04% | 453 |
|
|
2020
Q3 | $4.12M | Hold |
8,000
| – | – | 0.04% | 397 |
|
|
2020
Q2 | $3.61M | Sell |
8,000
-600
| -7% | -$271K | 0.05% | 401 |
|
|
2020
Q1 | $3.02M | Buy |
8,600
+1,500
| +21% | +$526K | 0.05% | 378 |
|
|
2019
Q4 | $2.63M | Buy |
+7,100
| New | +$2.63M | 0.03% | 511 |
|